BioCentury
ARTICLE | Company News

HealthCare Royalty in deals with Agenus, Albireo

January 8, 2018 10:46 PM UTC

Agenus Inc. (NASDAQ:AGEN) said it will sell to HealthCare Royalty Partners (Stamford, Conn.) royalty rights on sales of vaccines from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) containing Agenus' QS-21 Stimulon adjuvant. The biotech will receive $190 million in cash, plus up to $40 million in milestones.

Agenus gained $0.40 (11%) to $3.91 Monday...